Iveric Bio, a biopharmaceutical company, has announced promising new data from the GATHER trials for their drug, avacincaptad pegol. The drug is being developed to treat geographic atrophy (GA).
Read MoreGeographic atrophy is a condition where the cells in a specific part of the retina, called the macula, die off, leading to vision loss. The macula is responsible for sharp, central vision, and when it is affected, it can be difficult to read, drive or recognize faces.
Read MoreThe US Food and Drug Administration (FDA) recently approved a new treatment option for geographic atrophy, a form of dry age-related macular degeneration (AMD) that causes progressive vision loss. The new treatment, called pegcetacoplan injection, has been shown to significantly slow the progression of geographic atrophy and represents a major breakthrough in the management of this debilitating condition.
Read MoreDiabetes and Pregnancy
Read MorePatient View: Cure for Type 2 Diabetes?
Read MorePatient View: How to Protect Your Aging Eyes
Read MoreChocolate consumption & Nobel Prize winners
Read MoreMost Feared Medical Condition: Blindness
Read MorePatient View: Yearly Eye Exams: Why?
Read More